Grantclosed🌐 United StatesRFA-DA-26-020

Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)

National Institutes of Health

Details?

Posted: Sep 24, 2025
Response deadline: Jan 28, 2026, 12:00 AM UTC
Type: Grant
Category: 93.279
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-DA-26-020

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
United States · Jan 3, 2025
Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
United States · Jan 3, 2025
Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
United States · Aug 23, 2024
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Adult Residential Drug Medi-Cal Substance Use Disorder Treatment - P1 Drug Medi-Cal Medically Monitored W/drawal Management – Project 2 Adult Residential Drug Medi-Cal W/drawal Management Project 3
County of Orange · Feb 7, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.